These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36749855)

  • 21. The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders.
    Bi Y; Dzierba CD; Fink C; Garcia Y; Green M; Han J; Kwon S; Kumi G; Liang Z; Liu Y; Qiao Y; Zhang Y; Zipp G; Burford N; Ferrante M; Bertekap R; Lewis M; Cacace A; Westphal RS; Kimball D; Bronson JJ; Macor JE
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1443-7. PubMed ID: 25754495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist.
    Meirsman AC; Le Merrer J; Pellissier LP; Diaz J; Clesse D; Kieffer BL; Becker JA
    Biol Psychiatry; 2016 Jun; 79(11):917-27. PubMed ID: 26188600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remodeling of Sensorimotor Brain Connectivity in Gpr88-Deficient Mice.
    Arefin TM; Mechling AE; Meirsman AC; Bienert T; Hübner NS; Lee HL; Ben Hamida S; Ehrlich A; Roquet D; Hennig J; von Elverfeldt D; Kieffer BL; Harsan LA
    Brain Connect; 2017 Oct; 7(8):526-540. PubMed ID: 28882062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of 1-(1-benzothiophen-7-yl)-1H-pyrazole, a novel series of G protein-coupled receptor 52 (GPR52) agonists.
    Nakahata T; Tokumaru K; Ito Y; Ishii N; Setoh M; Shimizu Y; Harasawa T; Aoyama K; Hamada T; Kori M; Aso K
    Bioorg Med Chem; 2018 May; 26(8):1598-1608. PubMed ID: 29478803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The orphan receptor GPR88 blunts the signaling of opioid receptors and multiple striatal GPCRs.
    Laboute T; Gandía J; Pellissier LP; Corde Y; Rebeillard F; Gallo M; Gauthier C; Léauté A; Diaz J; Poupon A; Kieffer BL; Le Merrer J; Becker JA
    Elife; 2020 Jan; 9():. PubMed ID: 32003745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a Potent Human Trace Amine-Associated Receptor 1 Antagonist.
    Decker AM; Brackeen MF; Mohammadkhani A; Kormos CM; Hesk D; Borgland SL; Blough BE
    ACS Chem Neurosci; 2022 Apr; 13(7):1082-1095. PubMed ID: 35325532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPR88 in A
    Meirsman AC; de Kerchove d'Exaerde A; Kieffer BL; Ouagazzal AM
    Eur J Neurosci; 2017 Aug; 46(4):2026-2034. PubMed ID: 28700108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GPR88 in D1R-Type and D2R-Type Medium Spiny Neurons Differentially Regulates Affective and Motor Behavior.
    Meirsman AC; Ben Hamida S; Clarke E; de Kerchove d'Exaerde A; Darcq E; Kieffer BL
    eNeuro; 2019; 6(4):. PubMed ID: 31346000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of Potent and Brain-Penetrant GPR52 Agonist that Suppresses Psychostimulant Behavior.
    Wang P; Felsing DE; Chen H; Stutz SJ; Murphy RE; Cunningham KA; Allen JA; Zhou J
    J Med Chem; 2020 Nov; 63(22):13951-13972. PubMed ID: 33198466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders?
    Logue SF; Grauer SM; Paulsen J; Graf R; Taylor N; Sung MA; Zhang L; Hughes Z; Pulito VL; Liu F; Rosenzweig-Lipson S; Brandon NJ; Marquis KL; Bates B; Pausch M
    Mol Cell Neurosci; 2009 Dec; 42(4):438-47. PubMed ID: 19796684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The orphan receptor GPR88 controls impulsivity and is a risk factor for Attention-Deficit/Hyperactivity Disorder.
    Ben Hamida S; Sengupta SM; Clarke E; McNicholas M; Moroncini E; Darcq E; Ter-Stepanian M; Fortier MÈ; Grizenko N; Joober R; Kieffer BL
    Mol Psychiatry; 2022 Nov; 27(11):4662-4672. PubMed ID: 36075963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and pharmacological evaluation of 4-azolyl-benzamide derivatives as novel GPR52 agonists.
    Tokumaru K; Ito Y; Nomura I; Nakahata T; Shimizu Y; Kurimoto E; Aoyama K; Aso K
    Bioorg Med Chem; 2017 Jun; 25(12):3098-3115. PubMed ID: 28433511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible involvement of orphan receptors GPR88 and GPR124 in the development of hypertension in spontaneously hypertensive rat.
    Calderón-Zamora L; Ruiz-Hernandez A; Romero-Nava R; León-Sicairos N; Canizalez-Román A; Hong E; Huang F; Villafaña S
    Clin Exp Hypertens; 2017; 39(6):513-519. PubMed ID: 28678544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired working memory, cognitive flexibility and reward processing in mice genetically lacking Gpr88: Evidence for a key role for Gpr88 in multiple cortico-striatal-thalamic circuits.
    Thomson DM; Openshaw RL; Mitchell EJ; Kouskou M; Millan MJ; Mannoury la Cour C; Morris BJ; Pratt JA
    Genes Brain Behav; 2021 Feb; 20(2):e12710. PubMed ID: 33078498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Orphan GPCR Receptor, GPR88, Interacts with Nuclear Protein Partners in the Cerebral Cortex.
    Rebeillard F; De Gois S; Pietrancosta N; Mai TH; Lai-Kuen R; Kieffer BL; Giros B; Massart R; Darmon M; Diaz J
    Cereb Cortex; 2022 Jan; 32(3):479-489. PubMed ID: 34247243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia.
    Mantas I; Yang Y; Mannoury-la-Cour C; Millan MJ; Zhang X; Svenningsson P
    Neuropharmacology; 2020 Jan; 162():107829. PubMed ID: 31666199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental and adult expression patterns of the G-protein-coupled receptor GPR88 in the rat: Establishment of a dual nuclear-cytoplasmic localization.
    Massart R; Mignon V; Stanic J; Munoz-Tello P; Becker JA; Kieffer BL; Darmon M; Sokoloff P; Diaz J
    J Comp Neurol; 2016 Oct; 524(14):2776-802. PubMed ID: 26918661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local inactivation of Gpr88 in the nucleus accumbens attenuates behavioral deficits elicited by the neonatal administration of phencyclidine in rats.
    Ingallinesi M; Le Bouil L; Biguet NF; Thi AD; Mannoury la Cour C; Millan MJ; Ravassard P; Mallet J; Meloni R
    Mol Psychiatry; 2015 Aug; 20(8):951-8. PubMed ID: 25155879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GPR88 reveals a discrete function of primary cilia as selective insulators of GPCR cross-talk.
    Marley A; Choy RW; von Zastrow M
    PLoS One; 2013; 8(8):e70857. PubMed ID: 23936473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GPR88 is a critical regulator of feeding and body composition in mice.
    Lau J; Farzi A; Enriquez RF; Shi YC; Herzog H
    Sci Rep; 2017 Aug; 7(1):9912. PubMed ID: 28855710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.